Search research articles
Contact Us
Filters
Showing results (111-120 of 210) with videos related to
Page
of 21
Sort By:
Blood
|
January 1, 1995
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
B Falini, S Pileri, G Pizzolo, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1995
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease
G Nadali, F Vinante, A Rigo, et al.
Blood
|
April 1, 1990
Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia
L Trentin, R Zambello, C Agostini, et al.
British Journal of Haematology
|
August 1, 1990
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms
G Pizzolo, H Stein, O Josimovic-Alasevic, et al.
Leukemia Research
|
January 1, 1989
Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes
R Zambello, L Trentin, C Agostini, et al.
Blood Cancer Journal
|
July 26, 2012
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
A H Nwabo Kamdje, G Bassi, L Pacelli, et al.
Blood
|
August 1, 1987
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia
G Semenzato, R Foa, C Agostini, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders
F Vinante, A Vassanelli, R Zanotti, et al.
Annals of Hematology
|
October 12, 2012
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course
G De Matteis, D Veneri, F Aprili, et al.
American Journal of Clinical Pathology
|
August 1, 1989
Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features
M Chilosi, G Semenzato, F Vinante, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 210) with videos related to
Sort By:
Page
of 21
Blood
|
January 1, 1995
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
B Falini, S Pileri, G Pizzolo, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1995
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease
G Nadali, F Vinante, A Rigo, et al.
Blood
|
April 1, 1990
Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia
L Trentin, R Zambello, C Agostini, et al.
British Journal of Haematology
|
August 1, 1990
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms
G Pizzolo, H Stein, O Josimovic-Alasevic, et al.
Leukemia Research
|
January 1, 1989
Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes
R Zambello, L Trentin, C Agostini, et al.
Blood Cancer Journal
|
July 26, 2012
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
A H Nwabo Kamdje, G Bassi, L Pacelli, et al.
Blood
|
August 1, 1987
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia
G Semenzato, R Foa, C Agostini, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1995
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders
F Vinante, A Vassanelli, R Zanotti, et al.
Annals of Hematology
|
October 12, 2012
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course
G De Matteis, D Veneri, F Aprili, et al.
American Journal of Clinical Pathology
|
August 1, 1989
Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features
M Chilosi, G Semenzato, F Vinante, et al.
Page
of 21